Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration

<strong>Introduction </strong>The purpose of this study is to assess the ability of two new ECG markers (Regional Repolarisation Instability Index (R2I2) and Peak Electrical Restitution Slope) to predict sudden cardiac death (SCD) or ventricular arrhythmia (VA) events in patients with is...

Full description

Bibliographic Details
Main Authors: Ng, GA, Mistry, A, Newton, M, Schlindwein, FS, Barr, C, Bates, MG, Caldwell, J, Das, M, Farooq, M, Herring, N, Lambiase, P, Osman, F, Sohal, M, Staniforth, A, Tayebjee, M, Tomlinson, D, Whinnett, Z, Yue, A, Nicolson, WB
Format: Journal article
Language:English
Published: BMJ Publications 2022
_version_ 1797107287362371584
author Ng, GA
Mistry, A
Newton, M
Schlindwein, FS
Barr, C
Bates, MG
Caldwell, J
Das, M
Farooq, M
Herring, N
Lambiase, P
Osman, F
Sohal, M
Staniforth, A
Tayebjee, M
Tomlinson, D
Whinnett, Z
Yue, A
Nicolson, WB
author_facet Ng, GA
Mistry, A
Newton, M
Schlindwein, FS
Barr, C
Bates, MG
Caldwell, J
Das, M
Farooq, M
Herring, N
Lambiase, P
Osman, F
Sohal, M
Staniforth, A
Tayebjee, M
Tomlinson, D
Whinnett, Z
Yue, A
Nicolson, WB
author_sort Ng, GA
collection OXFORD
description <strong>Introduction </strong>The purpose of this study is to assess the ability of two new ECG markers (Regional Repolarisation Instability Index (R2I2) and Peak Electrical Restitution Slope) to predict sudden cardiac death (SCD) or ventricular arrhythmia (VA) events in patients with ischaemic cardiomyopathy undergoing implantation of an implantable cardioverter defibrillator for primary prevention indication. <br><strong> Methods and analysis </strong>Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction is a prospective, open label, single blinded, multicentre observational study to establish the efficacy of two ECG biomarkers in predicting VA risk. 440 participants with ischaemic cardiomyopathy undergoing routine first time implantable cardioverter-defibrillator (ICD) implantation for primary prevention indication are currently being recruited. An electrophysiological (EP) study is performed using a non-invasive programmed electrical stimulation protocol via the implanted device. All participants will undergo the EP study hence no randomisation is required. Participants will be followed up over a minimum of 18 months and up to 3 years. The first patient was recruited in August 2016 and the study will be completed at the final participant follow-up visit. The primary endpoint is ventricular fibrillation or sustained ventricular tachycardia >200 beats/min as recorded by the ICD. The secondary endpoint is SCD. Analysis of the ECG data obtained during the EP study will be performed by the core lab where blinding of patient health status and endpoints will be maintained. <br><strong> Ethics and dissemination </strong>Ethical approval has been granted by Research Ethics Committees Northern Ireland (reference no. 16/NI/0069). The results will inform the design of a definitive Randomised Controlled Trial (RCT). Dissemination will include peer reviewed journal articles reporting the qualitative and quantitative results, as well as presentations at conferences and lay summaries. <br><strong> Trial registration number </strong>NCT03022487.
first_indexed 2024-03-07T07:13:57Z
format Journal article
id oxford-uuid:81dd1691-427b-45fa-83c3-6dbf7d6b5b26
institution University of Oxford
language English
last_indexed 2024-03-07T07:13:57Z
publishDate 2022
publisher BMJ Publications
record_format dspace
spelling oxford-uuid:81dd1691-427b-45fa-83c3-6dbf7d6b5b262022-07-13T15:50:19ZRationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaborationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:81dd1691-427b-45fa-83c3-6dbf7d6b5b26EnglishSymplectic ElementsBMJ Publications2022Ng, GAMistry, ANewton, MSchlindwein, FSBarr, CBates, MGCaldwell, JDas, MFarooq, MHerring, NLambiase, POsman, FSohal, MStaniforth, ATayebjee, MTomlinson, DWhinnett, ZYue, ANicolson, WB<strong>Introduction </strong>The purpose of this study is to assess the ability of two new ECG markers (Regional Repolarisation Instability Index (R2I2) and Peak Electrical Restitution Slope) to predict sudden cardiac death (SCD) or ventricular arrhythmia (VA) events in patients with ischaemic cardiomyopathy undergoing implantation of an implantable cardioverter defibrillator for primary prevention indication. <br><strong> Methods and analysis </strong>Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction is a prospective, open label, single blinded, multicentre observational study to establish the efficacy of two ECG biomarkers in predicting VA risk. 440 participants with ischaemic cardiomyopathy undergoing routine first time implantable cardioverter-defibrillator (ICD) implantation for primary prevention indication are currently being recruited. An electrophysiological (EP) study is performed using a non-invasive programmed electrical stimulation protocol via the implanted device. All participants will undergo the EP study hence no randomisation is required. Participants will be followed up over a minimum of 18 months and up to 3 years. The first patient was recruited in August 2016 and the study will be completed at the final participant follow-up visit. The primary endpoint is ventricular fibrillation or sustained ventricular tachycardia >200 beats/min as recorded by the ICD. The secondary endpoint is SCD. Analysis of the ECG data obtained during the EP study will be performed by the core lab where blinding of patient health status and endpoints will be maintained. <br><strong> Ethics and dissemination </strong>Ethical approval has been granted by Research Ethics Committees Northern Ireland (reference no. 16/NI/0069). The results will inform the design of a definitive Randomised Controlled Trial (RCT). Dissemination will include peer reviewed journal articles reporting the qualitative and quantitative results, as well as presentations at conferences and lay summaries. <br><strong> Trial registration number </strong>NCT03022487.
spellingShingle Ng, GA
Mistry, A
Newton, M
Schlindwein, FS
Barr, C
Bates, MG
Caldwell, J
Das, M
Farooq, M
Herring, N
Lambiase, P
Osman, F
Sohal, M
Staniforth, A
Tayebjee, M
Tomlinson, D
Whinnett, Z
Yue, A
Nicolson, WB
Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title_full Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title_fullStr Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title_full_unstemmed Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title_short Rationale and study design of the MINERVA study: Multicentre Investigation of Novel Electrocardiogram Risk markers in Ventricular Arrhythmia prediction-UK multicentre collaboration
title_sort rationale and study design of the minerva study multicentre investigation of novel electrocardiogram risk markers in ventricular arrhythmia prediction uk multicentre collaboration
work_keys_str_mv AT ngga rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT mistrya rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT newtonm rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT schlindweinfs rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT barrc rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT batesmg rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT caldwellj rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT dasm rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT farooqm rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT herringn rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT lambiasep rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT osmanf rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT sohalm rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT stanifortha rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT tayebjeem rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT tomlinsond rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT whinnettz rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT yuea rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration
AT nicolsonwb rationaleandstudydesignoftheminervastudymulticentreinvestigationofnovelelectrocardiogramriskmarkersinventriculararrhythmiapredictionukmulticentrecollaboration